ClinicalTrialsFinder

Vorolanib Clinical Trials in Guangzhou, Other (Non U.s.)

1 recruitingGuangzhou, Other (Non U.s.), China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

Neoadjuvant TherapyClear-Cell Renal-Cell Carcinoma (ccRCC)Vorolanib
Sun Yat-sen University21 enrolled1 locationNCT07386158